Close

Form DEFA14A BIOGEN INC.

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/18/2024

1. LVS
2. TSM
3. SPY
4. NFLX
5. CSX
6. UAL
7. ALK
8. EFX
9. TSLA
10. MU


April 15, 2016 9:05 AM EDT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No.     )

 

 

Filed by the Registrant  x                              Filed by a Party other than the Registrant  ¨

Check the appropriate box:

 

¨   Preliminary Proxy Statement
¨   Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
¨   Definitive Proxy Statement
x   Definitive Additional Materials
¨   Soliciting Material under § 240.14a-12

    BIOGEN INC.    

(Name of Registrant as Specified In Its Charter)

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

x   No fee required.
¨   Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
  (1)  

Title of each class of securities to which transaction applies:

 

     

  (2)  

Aggregate number of securities to which transaction applies:

 

     

  (3)  

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

     

  (4)  

Proposed maximum aggregate value of transaction:

 

     

  (5)  

Total fee paid:

 

     

¨   Fee paid previously with preliminary materials.
¨   Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
  (1)  

Amount Previously Paid:

 

     

  (2)  

Form, Schedule or Registration Statement No.:

 

     

  (3)  

Filing Party:

 

     

  (4)  

Date Filed:

 

     

 

 

 

*** Exercise Your Right to Vote ***

Important Notice Regarding the Availability of Proxy Materials for the

Stockholder Meeting to Be Held on June 8, 2016.

 

 

BIOGEN INC.

 

LOGO

 

BIOGEN INC.

225 BINNEY STREET

CAMBRIDGE, MA 02142

LOGO  

 

Meeting Information

 

Meeting Type:        Annual Meeting

 

For holders as of:   April 11, 2016

 

Date: June 8, 2016  Time: 9:00 AM Eastern Daylight Time

 

Location:     Meeting live via the Internet-please visit

     www.virtualshareholdermeeting.com/BIIB.

The company will be hosting the meeting live via the Internet this year. To attend the meeting via the Internet please visit www.virtualshareholdermeeting.com/BIIB and be sure to have the information that is printed in the box marked by the arrow LOGO (located on the following page).

 

You are receiving this communication because you hold shares in the company named above.

This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).

We encourage you to access and review all of the important information contained in the proxy materials before voting.

 

See the reverse side of this notice to obtain proxy materials and voting instructions.

 

— Before You Vote —

How to Access the Proxy Materials

 

  

 

Proxy Materials Available to VIEW or RECEIVE:

 

    
   2016 NOTICE AND PROXY STATEMENT             2015 ANNUAL REPORT WITH FORM 10-K    
  

 

How to View Online:

    
  

 

Have the information that is printed in the box marked by the arrow LOGO (located on the following page) and visit: www.proxyvote.com.

   
  

 

How to Request and Receive a PAPER or E-MAIL Copy:

    
  

 

If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:

    
  

 

1) BY INTERNET:

 

   

 

www.proxyvote.com

 

    
  

2) BY TELEPHONE:

 

   

1-800-579-1639

 

    
  

3) BY E-MAIL*:

    [email protected]    
  

 

*   If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow LOGO (located on the following page) in the subject line.

 

Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before May 25, 2016 to facilitate timely delivery.

 

    
  

 

— How To Vote —

Please Choose One of the Following Voting Methods

 

  
  

 

Vote By Internet:

         
  

 

Before The Meeting:

       
  

 

Go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow LOGO (located on the following page) available and follow the instructions.

    
LOGO        

 

During The Meeting:

 

Go to www.virtualshareholdermeeting.com/BIIB. Have the information that is printed in the box marked by the arrow LOGO (located on the following page) available and follow the instructions.

    
  

 

Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.

 

    

Voting Items        

The Board recommends a vote FOR the following proposals:

 

1. Election of Directors. To elect the eleven director nominees numbered 1a through 1k to serve for a one-year term extending until the 2017 annual meeting of stockholders and their successors are duly elected and qualified.

 

  1a. Alexander J. Denner

 

  1b. Caroline D. Dorsa

 

  1c. Nancy L. Leaming

 

  1d. Richard C. Mulligan

 

  1e. Robert W. Pangia

 

  1f. Stelios Papadopoulos

 

  1g. Brian S. Posner

 

  1h. Eric K. Rowinsky

 

  1i. George A. Scangos

 

  1j. Lynn Schenk

 

  1k. Stephen A. Sherwin
  2. To ratify the selection of PricewaterhouseCoopers LLP as Biogen Inc.’s independent registered public accounting firm for the fiscal year ending December 31, 2016.

 

  3. Say on Pay - To approve an advisory vote on executive compensation.

 

  4. To transact such other business as may be properly brought before the meeting and any adjournments or postponements thereof.
 

 

LOGO

 

 

 

 

 

 

    

LOGO


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings